- Report
- April 2022
- 40 Pages
India
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
Ireland
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
Japan
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
Russia
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
South Korea
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2022
- 100 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- March 2025
- 100 Pages
China
From €1638EUR$1,800USD£1,404GBP
- Report
- March 2019
- 16 Pages
Global
€9101EUR$10,000USD£7,802GBP
- Report
- October 2018
- 104 Pages
Global
From €2503EUR$2,750USD£2,146GBP
- Report
- March 2025
- 74 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2024
- 86 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
- 85 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2023
- 92 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- March 2025
- 211 Pages
China
From €3640EUR$4,000USD£3,121GBP
- Report
- February 2022
- 215 Pages
Global
From €3378EUR$3,712USD£2,896GBP

Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of drugs used to treat mental disorders such as depression, anxiety, and obsessive-compulsive disorder. SSRIs work by increasing the amount of serotonin, a neurotransmitter, in the brain. This helps to improve mood and reduce symptoms of mental illness. SSRIs are generally considered to be safer and more effective than other types of antidepressants, and they are often prescribed as a first-line treatment for mental disorders.
The SSRI market is highly competitive, with many pharmaceutical companies offering different brands of SSRIs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. These companies have developed a wide range of SSRIs, including Prozac, Zoloft, Paxil, and Lexapro. Other companies, such as Mylan and Teva, also offer generic versions of SSRIs. Show Less Read more